NaviFUS - Non-Invasive FUS Treatment for CNS Diseases
NaviFUS is a techhumanist__We make innovative and humancentered technology that can transform CNS disease patients' lives
Overview
NaviFUS Corporation is a medical device company specializing in non-invasive focused ultrasound (FUS) solutions for central nervous system (CNS) diseases, headquartered in Nangang District, Taipei City. The company develops precise and cost-effective FUS interventions to address clinically unmet needs, particularly for brain-related diseases that lack effective drug treatments. NaviFUS technology is based on research by founder Dr. Hao-Li Liu and includes two main platforms: the NaviFUS System FUS device, which can temporarily open the blood-brain barrier or help reduce epilepsy symptoms, and the NAVIRFA Needle Tracking System, which visualizes the location and trajectory of needles used in minimally invasive surgeries. The NaviFUS System has three models in development, including preclinical, animal therapy, and clinical research models, while the NAVIRFA system is being researched for applications in radiofrequency ablation, biopsy, and pain management.
Details
- Category
- Medical Device
- Headquarters
- Nangang District, Taipei City
- Type
- Public Company
- Founded
- 2015
- Followers
- 836
- Specialties
- Medical devices, Focused ultrasound, non-invasive FUS treatment, Blood-Brain-Barrier (BBB) Opening, and Neuromodulation
- Locations
- 16F., No. 508, Sec. 7, Zhongxiao E. Rd. Nangang District, Taipei City 115011, TW
Funding
Total rounds: 1
Last round: Seed, Feb 1, 2017